These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 18462868

  • 1. The inhibitory effect of p75 neurotrophin receptor on growth of human hepatocellular carcinoma cells.
    Yuanlong H, Haifeng J, Xiaoyin Z, Jialin S, Jie L, Li Y, Huahong X, Jiugang S, Yanglin P, Kaichun W, Jie D, Daiming F.
    Cancer Lett; 2008 Sep 08; 268(1):110-9. PubMed ID: 18462868
    [Abstract] [Full Text] [Related]

  • 2. The biological role of the low-affinity p75 neurotrophin receptor in esophageal squamous cell carcinoma.
    Okumura T, Tsunoda S, Mori Y, Ito T, Kikuchi K, Wang TC, Yasumoto S, Shimada Y.
    Clin Cancer Res; 2006 Sep 01; 12(17):5096-103. PubMed ID: 16951226
    [Abstract] [Full Text] [Related]

  • 3. p75NTR enhances PC12 cell tumor growth by a non-receptor mechanism involving downregulation of cyclin D2.
    Fritz MD, Mirnics ZK, Nylander KD, Schor NF.
    Exp Cell Res; 2006 Oct 15; 312(17):3287-97. PubMed ID: 16887120
    [Abstract] [Full Text] [Related]

  • 4. p75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells.
    Jin H, Pan Y, Zhao L, Zhai H, Li X, Sun L, He L, Chen Y, Hong L, Du Y, Fan D.
    Neoplasia; 2007 Jun 15; 9(6):471-8. PubMed ID: 17603629
    [Abstract] [Full Text] [Related]

  • 5. p75 neurotrophin receptor inhibits invasion and metastasis of gastric cancer.
    Jin H, Pan Y, He L, Zhai H, Li X, Zhao L, Sun L, Liu J, Hong L, Song J, Xie H, Gao J, Han S, Li Y, Fan D.
    Mol Cancer Res; 2007 May 15; 5(5):423-33. PubMed ID: 17510309
    [Abstract] [Full Text] [Related]

  • 6. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line.
    Mazzanti R, Platini F, Bottini C, Fantappiè O, Solazzo M, Tessitore L.
    Biochem Pharmacol; 2009 Jul 01; 78(1):21-32. PubMed ID: 19447220
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of ROBO1 as a novel hepatocellular carcinoma antigen and a potential therapeutic and diagnostic target.
    Ito H, Funahashi S, Yamauchi N, Shibahara J, Midorikawa Y, Kawai S, Kinoshita Y, Watanabe A, Hippo Y, Ohtomo T, Iwanari H, Nakajima A, Makuuchi M, Fukayama M, Hirata Y, Hamakubo T, Kodama T, Tsuchiya M, Aburatani H.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3257-64. PubMed ID: 16740745
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synemin down-regulation in human hepatocellular carcinoma does not destabilize cytoskeletons in vivo.
    Liu YH, Cheng CC, Lai YS, Chao WT, Pei RJ, Hsu YH, Ho CC.
    Biochem Biophys Res Commun; 2011 Jan 07; 404(1):488-93. PubMed ID: 21144834
    [Abstract] [Full Text] [Related]

  • 16. The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-alpha.
    Oie S, Ono M, Yano H, Maruyama Y, Terada T, Yamada Y, Ueno T, Kojiro M, Hirano K, Kuwano M.
    Int J Oncol; 2006 Dec 07; 29(6):1469-78. PubMed ID: 17088986
    [Abstract] [Full Text] [Related]

  • 17. Negatively regulating mechanism of Sirpalpha1 in hepatocellular carcinoma: an experimental study.
    Qin JM, Yan HX, Liu SQ, Wan XW, Zeng JZ, Cao HF, Qiu XH, Wu MC, Wang HY.
    Hepatobiliary Pancreat Dis Int; 2006 May 07; 5(2):246-51. PubMed ID: 16698585
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reduced expression of TANGO in colon and hepatocellular carcinomas.
    Arndt S, Bosserhoff AK.
    Oncol Rep; 2007 Oct 07; 18(4):885-91. PubMed ID: 17786351
    [Abstract] [Full Text] [Related]

  • 20. E2F8 contributes to human hepatocellular carcinoma via regulating cell proliferation.
    Deng Q, Wang Q, Zong WY, Zheng DL, Wen YX, Wang KS, Teng XM, Zhang X, Huang J, Han ZG.
    Cancer Res; 2010 Jan 15; 70(2):782-91. PubMed ID: 20068156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.